⌘K

Login Start Free

Home/Filings/4/0001209191-23-011384

4//SEC Filing

Pang Phillip 4

Accession 0001209191-23-011384

CIK 0001706431other

View on SEC.gov Company Profile

Filed

Feb 20, 7:00 PM ET

Accepted

Feb 21, 7:24 PM ET

Size

4.8 KB

Accession

0001209191-23-011384

Insider Transaction Report

Form 4

Period: 2023-02-17

Vir Biotechnology, Inc.VIR

Chief Medical Officer

Transactions

Sale
Common Stock
2023-02-17$25.29/sh−2,802$70,857→ 141,198 total

Footnotes (1)

[F1]Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Vir Biotechnology, Inc.

CIK 0001706431

Entity typeother

Related Parties

1

filerCIK 0001787370

Filing Metadata

Form type: 4
Filed: Feb 20, 7:00 PM ET
Accepted: Feb 21, 7:24 PM ET
Size: 4.8 KB

View on SEC.gov